Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GLGC Gene Logic -- Ignore unavailable to you. Want to Upgrade?

To: CrayUSA who wrote (140)	6/21/2000 9:08:00 AM
From: Linda Pearson	Respond to of 360

biz.yahoo.com <Tuesday June 20, 2:41 pm Eastern Time Groups in tug-of-war to announce genome map By Maggie Fox, Health and Science Correspondent WASHINGTON, June 20 (Reuters) - Scientists, health officials and politicians were in a trans-Atlantic tug-of-war on Tuesday to decide where, when and how to announce the completion of a rough draft of the human genome -- all the genes that make us what we are. With both the public and private efforts just about finished sequencing and assembling the human genome, British researchers on Tuesday told reporters they would call their own news conference next Monday to make the long-awaited announcement. They said they were coordinating with counterparts in United States. ``Details are still being worked out,'' a spokesman for the Sanger Centre at Britain's Cambridge University, which is doing a portion of the work of the publicly-funded Human Genome Project, said at a briefing.>

To: CrayUSA who wrote (140)	6/22/2000 8:25:00 AM
From: Linda Pearson	Respond to of 360

More about the announcement: cnetinvestor.com <<Wellcome Trust Schedules Gene Mapping Announcement (Update1) 6/21/00 1:33:00 PM Source: Bloomberg News London, June 21 (Bloomberg) -- The Wellcome Trust said it plans to announce Monday the completion of an international effort to create a working draft of the human genetic blueprint. The U.K.-based Wellcome Trust's Sanger Center is one of the participants in a five-nation public collaboration, known as the Human Genome Project, to decode the human genome. The U.S. portion of the effort, coordinated by the government's National Institutes of Health, has not yet scheduled an announcement. The Human Genome Project and PE Corp.'s Celera Genomics have both been rushing to finish a rough draft, spelling out the sequence of nearly all of the more than 3 billion DNA letters that make up the complete set of human genetic instructions. Newspaper reports have said Celera and the U.S. government were in talks on making a joint announcement, possibly at the White House. Celera officials didn't return calls seeking comment. The company has previously said it plans to finish its version of the rough draft in June. Celera shares have risen more than 35 percent in the last four trading days and more than 85 percent since the beginning of the year in anticipation of completion of its work on deciphering and assembling the human genome. The company's shares fell 1 5/8 to close at 136 5/8 in New York Stock Exchange trading. The Wellcome Trust, which is independent of British drugmaker Glaxo Wellcome Plc, is an endowed charity that directs most of its resources toward biomedical research. The Wellcome Trust owns 4.5 percent of Glaxo shares, according to the most recent regulatory filings. The deciphering and ordering of the multibillion-letter string of DNA, though it represents a milestone in the half- century effort to understand the human genetic blueprint, won't directly lead to better medicines or diagnostic tests. Attention next will turn to finding where genes lie in the DNA sequence and what functions those genes control, information that can be used to fashion better treatments. Though some work has already been done -- the location and function of some genes have been identified -- having a rough draft of the genome will make the search for other genes far easier.>>